Impact of metabolic parameters on [F-18] FDG PET/CT for patients with epithelial ovarian cancer undergoing neoadjuvant chemotherapy

被引：0
|
作者：
Palomar-Munoz, A. [1 ]
Pardo-Burdalo, B. [2 ]
Marti-Cardona, M. D. [3 ]
Reynes-Llompart, G. [4 ]
Suils-Ramon, J. [1 ]
Martinez-Ramos, C. V. [1 ]
Bondia-Bescos, S. [1 ]
Robles-Barba, J. J. [1 ]
Notta, P. C. [1 ]
Gracia-Sanchez, L. M. [1 ]
Cortes-Romera, M. [1 ]
机构：
[1] Hosp Univ Bellvitge IDIBELL, Nucl Med PET IDI Dept, Lhospitalet De Llobregat, Barcelona, Spain
[2] Hosp Duran i Reynals, Dept Med Oncol, Inst Catala Oncol, Lhospitalet De Llobregat, Barcelona, Spain
[3] Hosp Univ Bellvitge, Dept Gynecol & Obstet, Lhospitalet De Llobregat, Barcelona, Spain
[4] Hosp Univ Bellvitge IDIBELL, Dept Med Phys, Lhospitalet De Llobregat, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
219
引用
收藏
页码：S515 / S515
页数：1
相关论文
共 50 条
  • [21] Effects on 18F-FDG PET/CT Brain Glucose Metabolism in Rectal Cancer Patients Undergoing Neoadjuvant Chemotherapy
    Machado, Alexei M. C.
    Fagundes, Theara C.
    Mafra, Arnoldo
    Silva, Rodrigo G.
    Castro, Ana Carolina G.
    Mamede, Marcelo
    [J]. CLINICAL NUCLEAR MEDICINE, 2017, 42 (12) : E484 - E490
  • [22] Prognostic value of 18F-FDG PET/CT parameters in recurrent epithelial ovarian cancer
    Mayoral, M.
    Fernandez, A.
    Paredes, P.
    Vidai, L.
    Fuster, D.
    Depetris, M.
    Granados, U.
    Pons, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S202 - S203
  • [23] Management Impact of F-18 FDG PET/CT Scan in Differentitated Thyroid Cancer Patients
    Hassan, Aamna
    Riaz, Saima
    Bashir, Humayun
    Nawaz, M. Khalid
    Hussain, Raza
    Khan, Amina
    Syed, Aamir A.
    Shah, Mazhar A.
    Murtaza, Ahmad
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [24] 18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer
    Tuulia Vallius
    Johanna Hynninen
    Jukka Kemppainen
    Victor Alves
    Kari Auranen
    Jaakko Matomäki
    Sinikka Oksa
    Johanna Virtanen
    Seija Grénman
    Annika Auranen
    Marko Seppänen
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1224 - 1232
  • [25] 18F-FDG-PET/CT based total metabolic tumor volume change during neoadjuvant chemotherapy predicts outcome in advanced epithelial ovarian cancer
    Vallius, Tuulia
    Hynninen, Johanna
    Kemppainen, Jukka
    Alves, Victor
    Auranen, Kari
    Matomaki, Jaakko
    Oksa, Sinikka
    Virtanen, Johanna
    Grenman, Seija
    Auranen, Annika
    Seppanen, Marko
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1224 - 1232
  • [26] Prognostic Value of metabolic parameters on Pretreatment F-18 FDG PET/CT in Patients with Advanced melanomatreated with Pembrolizumab
    Ito, Kimiteru
    Michaud, Laure
    Nakajima, Reiko
    Weber, Wolfgang
    Schoder, Heiko
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [27] Prognostic value of maximum standardized uptake value measured on F-18 FDG PET/CT in patients with recurrent epithelial ovarian cancer
    Palard, X.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S251 - S251
  • [28] Tumor heterogeneity with F-18 FDG PET/CT in patients with breast cancer
    Garai, I.
    Ioannou, A.
    Galgoczy, H.
    Oszlanszki, A.
    Forgacs, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S475 - S475
  • [29] Metabolic Pattern of Glomic Tumor by F-18 FDG PET/CT
    de Marco, Luisa
    Mamede, Marcelo
    [J]. CLINICAL NUCLEAR MEDICINE, 2011, 36 (11) : 1051 - 1052
  • [30] Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
    Chung, Young Shin
    Kim, Hyun-Soo
    Lee, Jung-Yun
    Kang, Won Jun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    [J]. CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1211 - 1218
12345